Evaluation of TAM Receptor Targeting in Pathophysiology of Idiopathic Pulmonary Fibrosis

Nicole Vercellino1, Luciana L Ferreira1, Elisa Zoppis2

  • 1Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

PubMed

Insights

The Gas6/TAM system plays a role in fibrosis. Inhibiting TAM signaling with R428 and LDC1267 modulates fibroblast activity and impacts macrophage polarization in fibrotic lung disease.

Area of Science:

  • Cell Biology
  • Immunology
  • Pharmacology

Background:

  • The Growth Arrest-Specific 6 (Gas6)/TAM receptor system (Tyro3, Axl, Mer) is implicated in fibrotic diseases.
  • Elevated Gas6 and Axl expression are noted in Idiopathic Pulmonary Fibrosis (IPF) lung samples and fibroblasts.

Purpose of the Study:

  • To investigate the role of the Gas6/TAM system in fibrosis development.
  • To assess the effects of pharmacological inhibition of the Gas6/TAM system on fibroblast function.

Main Methods:

  • Idiopathic Pulmonary Fibrosis (IPF) fibroblasts and human pulmonary fibroblasts (HPFs) were treated with Axl-specific inhibitor (R428), a TAM inhibitor (LDC1267), or Nintedanib.
  • Assessed fibroblast proliferation, migration, and gene expression (pro-inflammatory and pro-fibrotic markers) following TGF-β induction.
  • Investigated fibroblast-macrophage interactions and their impact on macrophage polarization (M1/M2 markers).

Main Results:

  • R428 demonstrated a higher inhibitory impact on IPF fibroblast proliferation compared to controls.
  • LDC1267 and R428 treatments reduced fibroblast migration and the expression of key pro-fibrotic genes (ACTA2, COL1A1, FN1).
  • Fibroblast-macrophage co-cultures showed altered expression of macrophage polarization markers, indicating intercellular crosstalk.

Conclusions:

  • R428 and LDC1267 effectively modulate fibroblast proliferation, migration, and gene expression through TAM signaling pathways.
  • Fibroblast interactions influence macrophage polarization, highlighting the importance of intercellular communication in fibrotic diseases.
  • Targeting the Gas6/TAM system presents a potential therapeutic strategy for fibrotic conditions like IPF.